Optimal Dose of Vitamin D in COVID-19: Survey of 2338 Indian Doctors brings in a First time consensus

New Delhi: Vitamin D levels of 40 ng/mL and above confer a better immune-protective response to several infections, including COVID-19, a pan India Survey of 2,338 pan-India Doctors has brought to consensus for the very first time.

For the first time in India, Rastogi et al. issued a consensus statement to explain the therapeutic role of Vitamin D based on the systematic questionnaire-based and Knowledge, Attitudes and Practices (KAP) survey among 2,338 pan-India health care professionals (HCPs).

The observational study has been published in the Asian Journal of Diabetology issue.

Currently, there is a lack of consensus on the use of vitamin D for immune protection and the dose of vitamin D for either prevention or treatment of COVID-19. The goal of the accompanying consensus statement also includes arriving at common dosage and duration of vitamin D for immune modulatory function.

The expert panel highlights the immune-boosting potential of vitamin D and its potential role in decreasing morbidity, mortality, and ICU admission, especially in COVID-19 patients, through regulating cytokine storms via immunomodulatory actions.